You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 17, 2024

CLINICAL TRIALS PROFILE FOR SOTAGLIFLOZIN

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for sotagliflozin

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01742208 ↗	Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus	Completed	Sanofi	Phase 2	2013-02-01	This Phase 2 study was intended to assess the pharmacodynamics (PD), pharmacokinetics (PK), safety and efficacy of sotagliflozin following daily oral administration for 29 days in participants with type 1 diabetes mellitus (T1DM).
NCT01742208 ↗	Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus	Completed	Lexicon Pharmaceuticals	Phase 2	2013-02-01	This Phase 2 study was intended to assess the pharmacodynamics (PD), pharmacokinetics (PK), safety and efficacy of sotagliflozin following daily oral administration for 29 days in participants with type 1 diabetes mellitus (T1DM).
NCT02383940 ↗	Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C	Completed	Juvenile Diabetes Research Foundation	Phase 2	2015-04-01	This Phase 2 study was intended to demonstrate superiority of sotagliflozin versus placebo on Hemoglobin A1C (A1C) reduction at Week 12 in young adult participants with type 1 diabetes mellitus (T1DM) who have poor glycemic control on their current insulin regimen.
NCT02383940 ↗	Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C	Completed	Sanofi	Phase 2	2015-04-01	This Phase 2 study was intended to demonstrate superiority of sotagliflozin versus placebo on Hemoglobin A1C (A1C) reduction at Week 12 in young adult participants with type 1 diabetes mellitus (T1DM) who have poor glycemic control on their current insulin regimen.
NCT02383940 ↗	Efficacy and Safety of Sotagliflozin in Young Adult Patients With Type 1 Diabetes Mellitus and Elevated Hemoglobin A1C	Completed	Lexicon Pharmaceuticals	Phase 2	2015-04-01	This Phase 2 study was intended to demonstrate superiority of sotagliflozin versus placebo on Hemoglobin A1C (A1C) reduction at Week 12 in young adult participants with type 1 diabetes mellitus (T1DM) who have poor glycemic control on their current insulin regimen.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for sotagliflozin

Condition Name

Chart
Table

Condition Name for sotagliflozin
Intervention	Trials
Type 2 Diabetes Mellitus	19
Type 1 Diabetes Mellitus	7
Diabetes Mellitus	6
Healthy	3
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for sotagliflozin
Intervention	Trials
Diabetes Mellitus	33
Diabetes Mellitus, Type 2	19
Diabetes Mellitus, Type 1	9
Heart Failure	4
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for sotagliflozin

Trials by Country

Map
Table

Trials by Country for sotagliflozin
Location	Trials
United States	326
Canada	19
Germany	12
United Kingdom	11
Hungary	10
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for sotagliflozin
Location	Trials
Texas	20
Florida	18
California	16
North Carolina	16
Louisiana	12
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for sotagliflozin

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for sotagliflozin
Clinical Trial Phase	Trials
Phase 4	2
Phase 3	17
Phase 2	5
[disabled in preview]	15
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for sotagliflozin
Clinical Trial Phase	Trials
Completed	28
Terminated	6
Not yet recruiting	2
[disabled in preview]	3
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for sotagliflozin

Sponsor Name

Chart
Table

Sponsor Name for sotagliflozin
Sponsor	Trials
Sanofi	43
Lexicon Pharmaceuticals	21
Juvenile Diabetes Research Foundation	2
[disabled in preview]	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for sotagliflozin
Sponsor	Trials
Industry	64
Other	7
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.